Annual Reports

 
Quarterly Reports

  • 10-Q (May 15, 2014)
  • 10-Q (Nov 12, 2013)
  • 10-Q (Aug 19, 2013)
  • 10-Q (Aug 9, 2013)
  • 10-Q (Nov 14, 2012)
  • 10-Q (Aug 29, 2012)

 
8-K

 
Other

ERBA Diagnostics, Inc. 10-Q 2011

Documents found in this filing:

  1. 10-Q/A
  2. 10-Q/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 10-Q/A
Amendment No. 1

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2011

Commission File Number 1-14798

IVAX DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)

Delaware
11-3500746
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer Identification No.)


2140 North Miami Avenue, Miami, Florida 33127
(Address of principal executive offices)                (Zip Code)

(305) 324-2300
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes x     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes xNo o

 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o
Accelerated filer o
   
Non-accelerated filer o (Do not check if a smaller reporting company)
Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes o No x

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

34,391,554 shares of Common Stock, $ .01 par value, outstanding as of September 12, 2011.
 
 
 

 
 
Explanatory Note

The sole purpose of this Amendment No. 1 to IVAX Diagnostics, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2011, filed with the Securities and Exchange Commission on August 22, 2011 (the “Form 10-Q”), is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T.  Exhibit 101 to this report provides the consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).

No other changes have been made to the Form 10-Q.  This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.
 
 
2

 
 
PART II - OTHER INFORMATION

Item 6 - Exhibits

Exhibit
Number
 
Description
     
31.1
 
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
     
31.2
 
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
     
32.1
 
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 **
     
32.2
 
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 **
     
101.INS
 
XBRL Instance Document ***
 
   
101.SCH
 
XBRL Taxonomy Extension Schema Document ***
 
   
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document ***
 
   
101.LAB
 
XBRL Taxonomy Extension Labels Linkbase Document ***
 
   
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document ***
 
   
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document ***
 

*
Previously filed with the Quarterly Report on Form 10-Q filed with the SEC on August 22, 2011.
**
Previously furnished with the Quarterly Report on Form 10-Q filed with the SEC on August 22, 2011.
***
Pursuant to Rule 406T of SEC Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under these sections.

 
3

 

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
IVAX Diagnostics, Inc.
 
       
Date:  September 14, 2011    
By:
/s/ Arthur R. Levine  
   
Arthur R. Levine,
 
   
Chief Financial Officer
 
       

 
 
4

 
 
EXHIBIT INDEX


Exhibit
Number
 
Description
     
101.INS
 
XBRL Instance Document ***
 
   
101.SCH
 
XBRL Taxonomy Extension Schema Document ***
 
   
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document ***
 
   
101.LAB
 
XBRL Taxonomy Extension Labels Linkbase Document ***
 
   
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document ***
 
   
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document ***
 

***
Pursuant to Rule 406T of SEC Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under these sections.

 
 
5

 
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki